Description
IGF::OT::IGF CANCER SCREENING
First action · last action
2016-09-01 · 2016-09-01
Transactions
1
First transaction's obligation
$8,640
Base + all options value (sum of deltas)
$8,640
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-09-01+$8,640= $8,640
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-09-01 | +$8,640 | $8,640 | IGF::OT::IGF CANCER SCREENING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JMKGWGQLA7X7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426F0245 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $164,395 | FY2026 |
| 36C26125N0052 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $20,000 | FY2025 |
| 36C26123N0648 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2023 |
| 36C26123N0593 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $2,500 | FY2023 |
| 36C26122N0726 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2022 |
| 36C26122N0482 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · MEDICAL- LABORATORY TESTING | $0 | FY2022 |
Other recipients under Q301 from 626-NASHVILLE (00626) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24918N1412 | LABORATORY CORPORATION OF AMERICA | 626-NASHVILLE (00626) | $287,727 | FY2018 |
| VA24918F16052 | LABORATORY CORPORATION OF AMERICA | 626-NASHVILLE (00626) | $44,203 | FY2018 |
| VA24918F16050 | LABORATORY CORPORATION OF AMERICA | 626-NASHVILLE (00626) | $251,617 | FY2018 |
| VA24918F15897 | GENERAL ELECTRIC COMPANY | 626-NASHVILLE (00626) | $348,359 | FY2018 |
| VA24918J15366 | DIALYSIS CLINIC, INC. | 626-NASHVILLE (00626) | $90,000 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24916P4053_3600_-NONE-_-NONE- · retrieved 2026-09-26.